Why the IMNN-001 and PARP inhibitor pairing could matter more than the standalone data in ovarian cancer
FDA engagement signals cautious progress for AEON Biopharma Inc. in complex biologics space (NYSE American: AEON)
Read More General business news XYMOGEN enters sports nutrition with launch of XYMOGEN Athletix performance brand XYMOGEN launches XYMOGEN Athletix, an NSF Certified for Sport® line of supplements redefining performance nutrition for athletes at every level. bySoujanya RaviSeptember 24, 2025